Publication | Closed Access

Development and validation of a rapid reversed-phase HPLC method for the quantification of monoclonal antibody bevacizumab from polyester-based nanoparticles

NanomedicineNanotherapeuticsEngineeringMonoclonal Antibody BevacizumabImmunoengineeringImmunologyBioanalysisPolyester-based NanoparticlesImmunochemistryAntibody EngineeringBiomedical EngineeringAntibody ScreeningMedicineProtein NanoparticlesChromatography